TARA GETTINS: Open Payments
NPI 1023600152 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 37 payments from 13 companies in 2025. Trend: 2023 $718 · 2024 $1,156 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 7 | $212 |
| Otsuka America Pharmaceutical, Inc. | 7 | $157 |
| Novo Nordisk Inc | 2 | $136 |
| Amgen Inc. | 5 | $103 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| ANI Pharmaceuticals, Inc. | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Mallinckrodt Hospital Products Inc. | 2 | $46 |
| Ardelyx, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: Veltassa, JYNARQUE, KRYSTEXXA, FARXIGA, PURIFIED CORTROPHIN GEL, Kerendia, ACTHAR, IBSRELA.
Industry payments across FL — which companies pay providers there.
